Samir V. Parikh - Concepedia

Author

Samir V. Parikh

The Ohio State University Wexner Medical Center ORCID

Also Known As

Brad Rovin, John P. Shapiro, Jorge Paoli-Bruno, Parikh, S., Parikh, Samir, S Parikh, S. Parikh, Samir Parikh, Samir V Parikh, Samir V. Parikh

107

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Wexner Medical Center The Ohio State University University of Washington Indiana University – Purdue University Indianapolis Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

About

Samir V. Parikh is an author at The Ohio State University Wexner Medical Center specializing in medicine, nephrology, and lupus.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.3K
2	Engineering	2	2	239
3	Biomedical Engineering	2	2	239
4	Health Sciences	1	1	11
5	Biostatistics	1	1	80

Samir V. Parikh

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
An atlas of healthy and injured cell states and niches in the human kidney Blue B. Lake, Rajasree Menon, Seth Winfree, Nature	2023	568
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler, The Lancet GlomerulonephritisAutoimmune DiseaseVoclosporin Versus PlaceboSystemic Lupus Erythematosus TreatmentLupus	2021	534
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis Brad H. Rovin, Neil Solomons, William F. Pendergraft, Kidney International Dose-ranging VoclosporinGlomerulonephritisAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentLupus	2018	290
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis Yemil Atisha‐Fregoso, Susan Malkiel, Kristina M. Harris, Arthritis & Rheumatology	2020	197
A reference tissue atlas for the human kidney Jens Hansen, Rachel Sealfon, Rajasree Menon, Science Advances EngineeringRenal PathologyIntegrated Reference MapReference Tissue AtlasKidney Disease	2022	159
Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis Samir V. Parikh, Haikady N. Nagaraja, Lee A. Hebert, Clinical Journal of the American Society of Nephrology	2013	116
Safety and Efficacy of <scp>Long‐Term</scp> Voclosporin Treatment for Lupus Nephritis in the Phase 3 <scp>AURORA</scp> 2 Clinical Trial Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson, Arthritis & Rheumatology	2023	90
Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy Mariana Cárdenas‐González, Anand Srivastava, Mira Pavkovic, Clinical Chemistry	2017	86
A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project Tarek M. El‐Achkar, Michael T. Eadon, Rajasree Menon, Physiological Genomics EngineeringRenal PathologyBiomedical EngineeringSpatial OmicsIntegrated Approach	2020	80
Association Between Urinary Epidermal Growth Factor and Renal Prognosis in Lupus Nephritis Juan M. Mejía‐Vilet, John P. Shapiro, Xiaolan L. Zhang, Arthritis & Rheumatology	2020	54

Page 1